FDA Inspection
Organon Pharma (UK) Ltd.Organon Pharma (UK) Ltd. – FDA Inspection, Jun 13, 2025
Record Details
This FDA Inspection record concerns Organon Pharma (UK) Ltd., with an inspection on June 13, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 958fa922-0d03-42b3-8bce-853e097a72e2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1273172
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.84(d)(2)Component written specification
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Organon Pharma (UK) Ltd.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| June 14, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 6, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 22, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 9, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Organon Pharma (UK) Ltd.
- FDA Inspection 1093308 - 2018-06-14
- FDA Inspection 916040 - 2015-02-06
- FDA Inspection 826684 - 2013-03-22
- FDA Inspection 651971 - 2010-03-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.